XXXue Xia

Xue Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xue Xia has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Yansong Li

    School of Physical Education, Qingdao University, Qingdao, China

    2 shared publications
  • Bo Zhou

    Sichuan Provincial Center for Mental Health, The Center of Psychosomatic Medicine of Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China

    1 shared publication
  • Chengcheng Li

    Department of Pediatric, Yangpu District Shidong Hospital, Shanghai, China

    1 shared publication
  • Chenghui Yang

    Sichuan Provincial Center for Mental Health, The Center of Psychosomatic Medicine of Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China

    1 shared publication
  • Cui Yuan

    Sichuan Provincial Center for Mental Health, The Center of Psychosomatic Medicine of Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China

    1 shared publication
  • Fan Chang

    Sichuan Provincial Center for Mental Health, The Center of Psychosomatic Medicine of Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China

    1 shared publication

Latest Publications

  • Open Access

    Nogo-related frontal theta-band activity after magnetic seizure therapy in treatment-resistant depression: an exploratory task-based EEG study

    by Lu Yuan, Fan Chang, Chenghui Yang, Cui Yuan, Bo Zhou, Yuejia Luo, Ruifeng Shi, Yihan Su, Xue Xia, Ying He

    Introduction: Magnetic seizure therapy (MST) is an emerging convulsive treatment for treatment-resistant depression (TRD) with efficacy comparable to electroconvulsive therapy and superior cognitive safety. However, its neurophysiological mechanisms—particularly those underlying conflict monitoring and response inhibition—remain unclear. Frontal midline theta-band activity indexes anterior cingulate–prefrontal cognitive-control activity and may reflect inefficient neural processing in depression. Methods: In this open-label, single-arm trial, 19 patients with TRD (16 female; mean age 20.89 ± 8.16 years; 10 of the 19 participants were minors) received 6–12 MST sessions using 100-Hz double-cone coil stimulation targeting bilateral F3/F4 frontal regions. Clinical assessments, including the 24-item Hamilton Depression Rating Scale (HAMD-24), Hamilton Anxiety Rating Scale (HAMA), Montgomery-Åsberg Depression Rating Scale (MADRS), and 64-channel Go/Nogo task-based electroencephalography (EEG), were performed before and after treatment. EEG outcome measures included event-related potentials (N2/P3), time-frequency power (theta/beta), microstate dynamics, and theta–beta cross-frequency coupling. Results: Following MST, patients showed significant reductions in depressive symptoms (HAMD: 40.53 ± 10.25 to 22.53 ± 11.21; MADRS: 35.68 ± 8.84 to 20.68 ± 11.12). Response rates ranged from 42.1% to 57.9%. Behavioral data could not be formally analyzed due to incomplete data storage. At an uncorrected threshold, total Nogo-related theta-band activity (4–7 Hz) at Fz and FCz was lower after treatment; however, these effects did not survive FDR correction. ERP amplitudes did not change significantly. Exploratory microstate analysis showed nominal changes in Map4 AUC during Go processing and Map2 duration during Nogo processing; none survived FDR correction. These parameters should not be interpreted as reflecting changes in neural activation or inhibitory preparation. No significant changes were observed in theta–beta cross-frequency coupling or Go-condition theta power. Discussion: These preliminary findings suggest that MST was associated with short-term symptom improvement and lower total Nogo-related theta-band activity at an uncorrected threshold. Because no control group, complete behavioral data, normative comparison, Time × Condition interaction, or EEG-clinical association was available, these findings cannot establish causal mechanisms, condition specificity, improved neural efficiency, or biomarker utility. Replication in adequately powered controlled studies with complete behavioral and longitudinal clinical measures is required.

  • Open Access

    Physical Activity, Rumination, and Social Interaction Anxiety in Adolescents: A Cross-Sectional Moderated Network Analysis

    by Pengfei Ji, Yongxin Wang, Jirui Qiu, Yansong Li, Xue Xia

    (1) Background: Rumination is closely associated with adolescent social interaction anxiety, and physical activity has been linked to both repetitive negative thinking and anxiety-related symptoms. This study examined the network relationships between different dimensions of rumination and social interaction anxiety and explored the moderating role of physical activity level. (2) Methods: A total of 1194 adolescents aged 14–18 years (525 boys, 669 girls; M = 16.27, SD = 0.80) completed measures of rumination, social interaction anxiety, and physical activity. A moderated network model was estimated using the modnets package in R, and bootstrap procedures were used to assess network accuracy and stability. (3) Results: All rumination dimensions were positively connected, with the strongest association between symptom rumination and reflective pondering. Brooding showed the largest conditional association with social interaction anxiety among the three rumination dimensions and the highest expected influence. At higher physical activity levels, the estimated positive conditional association between symptom rumination and brooding was weaker, the association between reflective pondering and brooding was stronger, and the association between brooding and social interaction anxiety was weaker. (4) Conclusions: In the estimated network, brooding showed the highest expected influence and the largest conditional association with social interaction anxiety among the three rumination dimensions. Several estimated conditional associations involving brooding differed across physical activity levels. However, given the cross-sectional design and the limited stability of the interaction estimates, these moderation patterns should be regarded as exploratory. They reflect correlational differences in the estimated network across physical activity levels rather than evidence of a protective effect of physical activity.


  • Open Access

    School connectedness and adolescents’ problematic smartphone use: a cross-lagged model mediated by depressive symptoms

    by Yansong Li, Ke Wang, Qilong Sun, Yuanjun Dong, Zuxian Li, Xue Xia

    With the rapid development of information technology, problematic smartphone use (PSU) has become increasingly prevalent among adolescents, posing risks to their psychological well-being and healthy development. Identifying the protective factors and underlying psychological mechanisms of PSU is critical for developing effective interventions. School connectedness, a key element of adolescents’ social environment, may serve as a buffer against psychological distress and behavioral problems, yet its longitudinal influence on PSU remains underexplored. A sample of 419 Chinese adolescents (mean age = 16.34 years, SD = 0.71; 67.3% female) completed the School Connectedness Scale, Center for Epidemiologic Studies Depression Scale, and Self-rating Questionnaire for Adolescent Phone Use in April 2023 (Time 1) and October 2023 (Time 2). A cross-lagged panel model was employed to examine the directional associations among these variables over time. Furthermore, a semi-longitudinal mediation model was constructed to investigate whether depressive symptoms reflect an indirect pathway between school connectedness and PSU. Analyses from the cross-lagged and semi-longitudinal mediation models revealed that the pattern of results is consistent with an indirect association linking school connectedness to PSU via depressive symptoms. Specifically, school connectedness at T1 was negatively associated with depressive symptoms at T2, and depressive symptoms at T1 were positively associated with PSU at T2. These findings highlight school connectedness may serve as a potential protective factor in mitigating adolescent PSU by alleviating depressive symptoms. Interventions aiming to enhance adolescents’ sense of school belonging may help reduce emotional distress and lower the risk of PSU.

  • Open Access

    Amelioration of emotional processing deficits in individuals with high trait anxiety following high-intensity interval training

    by Chengcheng Li, Xiaoyi Che, Jingjing Yu, Fei Yan, Yu Fang, Pengjun Zhao, Jian Zhang, Lin Zhao, Xue Xia

    How does exercise alleviate anxiety related emotional processing deficits? This study measured the effect of both high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on motor cortical excitability corresponding to emotional perception in individuals with high trait anxiety. Participants included 16 adults (10 women) with high trait anxiety and were asked to execute an emotion recognition task before and after HIIT, MICT and a control session. During the task, Transcranial magnetic stimulation was applied to the right primary motor cortex 150 ms (early stage) or 300 ms (late stage) after the onset of positive, negative, or neutral images, with the motor-evoked potential (MEP) amplitudes measured. State anxiety was measured using the state portion of the State-Trait Anxiety Inventory. It showed that at 150 ms, HIIT increased MEP amplitudes corresponding to negative stimuli (p < 0.001), and MICT increased MEP amplitudes corresponding to positive stimuli (p = 0.022). State anxiety score was decreased only after HIIT (p = 0.027). Both HIIT and MICT could ameliorate emotional processing deficits by enhancing motor cortical excitability corresponding to emotional perception, and the improvement especially to negative emotions perception by HIIT may be more important for alleviating anxiety. The trial was retrospectively registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2500108605; date: 2025/09/02).